Stockreport

AstraZeneca Imfinzi regimen for endometrial cancer gains FDA approval [Yahoo! Finance]

AstraZeneca PLC - American Depositary Shares  (AZN) 
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm Check Earnings Report
US:NYSE Investor Relations: astrazeneca.com/investor-relations.html
PDF treating adults with primary advanced or recurrent endometrial cancer that is mismatch repair deficient (dMMR). The treatment regimen comprises Imfinzi plus chemothera [Read more]